Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,200 | 1 | 64.4% |
| Food and Beverage | $563.25 | 10 | 30.2% |
| Education | $99.00 | 1 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $1,216 | 5 | $0 (2021) |
| Inspire Medical Systems, Inc. | $215.26 | 2 | $0 (2023) |
| Mylan Specialty L.P. | $118.91 | 1 | $0 (2020) |
| Harmony Biosciences LLC | $118.71 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $99.00 | 1 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $79.54 | 1 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.02 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $296.35 | 3 | Harmony Biosciences LLC ($118.71) |
| 2022 | $15.02 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($15.02) |
| 2021 | $1,216 | 5 | Biohaven Pharmaceuticals, Inc. ($1,216) |
| 2020 | $118.91 | 1 | Mylan Specialty L.P. ($118.91) |
| 2019 | $117.16 | 1 | Inspire Medical Systems, Inc. ($117.16) |
| 2017 | $99.00 | 1 | Novartis Pharmaceuticals Corporation ($99.00) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $79.54 | General |
| Category: INSOMNIA | ||||||
| 04/19/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $118.71 | General |
| Category: SLEEP MEDICINE | ||||||
| 01/19/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $98.10 | General |
| Category: NEUROLOGY | ||||||
| 01/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: PRIMARY CARE | ||||||
| 12/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: PRIMARY CARE | ||||||
| 12/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: PRIMARY CARE | ||||||
| 10/09/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: PRIMARY CARE | ||||||
| 09/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: PRIMARY CARE | ||||||
| 08/11/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: PRIMARY CARE | ||||||
| 02/05/2020 | Mylan Specialty L.P. | — | Food and Beverage | In-kind items and services | $118.91 | General |
| 11/06/2019 | Inspire Medical Systems, Inc. | Inspire Upper Airway Stimulation System (Device) | Food and Beverage | Cash or cash equivalent | $117.16 | General |
| Category: Neurology | ||||||
| 09/20/2017 | Novartis Pharmaceuticals Corporation | — | Education | In-kind items and services | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 200 | 315 | $61,455 | $33,639 |
| 2022 | 2 | 211 | 355 | $66,485 | $39,355 |
| 2021 | 2 | 219 | 353 | $66,770 | $40,571 |
| 2020 | 3 | 168 | 255 | $48,525 | $26,555 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 284 | $48,280 | $29,629 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $13,175 | $4,010 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 323 | $53,200 | $34,734 | 65.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $13,285 | $4,621 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 303 | $46,870 | $33,507 | 71.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $19,900 | $7,064 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 198 | $29,700 | $19,374 | 65.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 45 | 45 | $17,325 | $6,346 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,500 | $835.01 | 55.7% |
About Dr. Jeremy Abbott, DDS
Dr. Jeremy Abbott, DDS is a Orofacial Pain healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891857074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremy Abbott, DDS has received a total of $1,862 in payments from pharmaceutical and medical device companies, with $296.35 received in 2023. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($1,200).
As a Medicare-enrolled provider, Abbott has provided services to 798 Medicare beneficiaries, totaling 1,278 services with total Medicare billing of $140,120. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Orofacial Pain
- Other Specialties Oral and Maxillofacial Surgery, Dentist
- Location Rockville, MD
- Active Since 12/14/2006
- Last Updated 01/23/2024
- Taxonomy Code 1223X2210X
- Entity Type Individual
- NPI Number 1891857074
Products in Payments
- NURTEC ODT (Drug) $1,231
- WAKIX (Drug) $118.71
- Inspire Upper Airway Stimulation System (Device) $117.16
- INSPIRE (Device) $98.10
- QUVIVIQ (Drug) $79.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.